In 2024, MB "IVB Pharma Consulting" had revenue of 256.9 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 256,9k € +15.1% | 223,2k € | 0 € |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - -100.0% | 183,7k € +26.1% | 145,6k € |
Employees | - | - | - |
Overall rating | B71/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 75/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Female) |
MB "IVB Pharma Consulting" is located at Kaunas, Ramybės g. 50, LT-47161, LT-LT-47161.
The shareholders of MB "IVB Pharma Consulting" include 1 Lithuanian legal entities. View ownership details →
Yes, MB "IVB Pharma Consulting" is registered as an active VAT payer with VAT number LT100012595915.
MB "IVB Pharma Consulting" was founded on April 16, 2018. The company has been operating for 8 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 8 years | 598 - 602 | 62% | |
Net revenue | 256 854,00 € | 228 - 232 | 85% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.